Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Dynamite News
Dynamite News
National
DN Bureau

Know how novel immune cell therapy can fight hepatitis B infections

Representational image

Washington: Researchers found out how chronic infection with the hepatitis B virus (HBV) causes gradual liver damage, and eradicating the virus remains a daunting challenge.

According to new research published in FEBS Letters, therapy that amplifies the impact of immune cells known as stem cell memory T cells (TSCMs) could be a promising technique for treating HBV.

In the study, investigators identified TSCMs in patients with chronic HBV infection and analyzed their effects in a mouse model of HBV.

After introducing TSCMs from patients into the mice, the immune cells differentiated into cytotoxic T cells and activated a strong response that resulted in the elimination of HBV-infected liver cells.

Therefore, augmenting patients' TSCMs may help the immune system overcome the virus.

"Our hepatitis model may reveal how TSCMs differentiate into cytotoxic T cells and uncover the fate of differentiated T cells.

Such information could greatly advance future research on T cell-based therapies," said corresponding author Hiromi Abe-Chayama, PhD, of Hiroshima University, in Japan.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.